These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 11867017)

  • 1. Management of genital herpes in HIV-infected patients.
    Aoki FY
    Herpes; 2001 Jul; 8(2):41-5. PubMed ID: 11867017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome.
    McGrath BJ; Newman CL
    Pharmacotherapy; 1994; 14(5):529-42. PubMed ID: 7997387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
    Baumann R; Wunderli W; Riess C; Vogt M
    Schweiz Med Wochenschr; 1993 Dec; 123(51-52):2394-400. PubMed ID: 8290931
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons.
    Strick LB; Wald A; Celum C
    Clin Infect Dis; 2006 Aug; 43(3):347-56. PubMed ID: 16804851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
    Ruark AH; Shelton JD; Halperin DT
    N Engl J Med; 2010 May; 362(18):1741; author reply 1741-2. PubMed ID: 20449879
    [No Abstract]   [Full Text] [Related]  

  • 6. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
    Gray R; Wilson D
    N Engl J Med; 2010 May; 362(18):1740; author reply 1741-2. PubMed ID: 20445189
    [No Abstract]   [Full Text] [Related]  

  • 7. Herpes simplex and HIV infections and preterm PROM.
    Ehsanipoor RM; Major CA
    Clin Obstet Gynecol; 2011 Jun; 54(2):330-6. PubMed ID: 21508703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSV-2 and HIV: consequences of an endemic opportunistic infection.
    Wald A; Schacker T; Corey L
    STEP Perspect; 1997; 9(3):2-4. PubMed ID: 11364936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
    N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
    DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
    J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance of herpes simplex viruses to antiviral drugs].
    Scieux C; Bianchi A
    Pathol Biol (Paris); 1993 Feb; 41(2):172-7. PubMed ID: 8392160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
    Celum CL; Robinson NJ; Cohen MS
    J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of genital herpes infections in HIV-infected patients.
    Foley E; Patel R
    J HIV Ther; 2004 Feb; 9(1):14-8. PubMed ID: 15071425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report.
    Alvarez-McLeod A; Havlik J; Drew KE
    Clin Infect Dis; 1999 Oct; 29(4):937-8. PubMed ID: 10589917
    [No Abstract]   [Full Text] [Related]  

  • 15. An update on short-course episodic and prevention therapies for herpes genitalis.
    Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of anti-HSV therapeutics in the HIV-infected host and in controlling the HIV epidemic.
    Barton S; Celum C; Shacker TW
    Herpes; 2005 Jun; 12(1):15-22. PubMed ID: 16026640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSV shedding.
    Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
    Antiviral Res; 2004 Aug; 63 Suppl 1():S19-26. PubMed ID: 15450382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of genital herpes infection.
    Lavoie SR; Kaplowitz LG
    Semin Dermatol; 1994 Dec; 13(4):248-55. PubMed ID: 7848818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.